Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.

Canadian family physician Medecin de famille canadien - 1 May 2012

Vanstone Meredith, Chow Winsion, Lester Laura, Ainsworth Peter, Nisker Jeff, Brackstone Muriel

Abstract excerpt

OBJECTIVE: To describe the population of women in southwestern Ontario who were diagnosed with potentially preventable BRCA mutation-related breast cancer. DESIGN: Retrospective chart review. SETTING: The Cancer Genetics Clinic of the London Regional Cancer Program in London, Ont. PARTICIPANTS: Patients younger than 52 years of age who were referred to the London Regional Cancer Program Cancer Genetics Clinic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to DNA, Neoplasm

Share to Genetic Testing

Share to Incidence

Share to Ontario

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 22734169
PMCID: PMC3352812

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.PMID 22734169Read ↗

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.Semantic proximity Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.Semantic proximity Read ↗

Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study.Semantic proximity Read ↗

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.Semantic proximity Read ↗

Routine TP53 testing for breast cancer under age 30: ready for prime time?Semantic proximity Read ↗

Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.Semantic proximity Read ↗

Testing for hereditary breast and ovarian cancer in the southeastern United States.Semantic proximity Read ↗

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.Semantic proximity Read ↗

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.